{
  "features": {
    "nct_id": 0,
    "start_date": 0,
    "study_type": "Interventional",
    "overall_status": "Completed",
    "phase": "Phase 2",
    "number_of_arms": 1,
    "why_stopped": "None",
    "has_dmc": 0,
    "is_fda_regulated_drug": 1,
    "start_year": 2020,
    "target": "Cancer",
    "covid_exposure": 0,
    "includes_us": 1,
    "allocation": "Randomized",
    "intervention_model": "Parallel Assignment",
    "primary_purpose": "Treatment",
    "masking": "None",
    "num_primary_endpoints": 1,
    "lead_sponsor": "SponsorA",
    "agency_class": "Industry",
    "sponsor_clean": "SponsorA",
    "sponsor_tier": 2,
    "gender": "All",
    "healthy_volunteers": 0,
    "criteria_len_log": 3.1,
    "child": 0,
    "adult": 1,
    "older_adult": 0,
    "best_pathology": "Solid Tumor",
    "therapeutic_area": "Oncology",
    "tree_number": 0,
    "therapeutic_subgroup_name": "General",
    "competition_broad": 1,
    "competition_niche": 0,
    "txt_tags": "none",
    "txt_criteria": "none",
    "name": "Trial name",
    "agent_category": "Drug",
    "score_masking": 0.5,
    "score_allocation": 0.5,
    "score_model": 0.5,
    "design_rigor_score": 0.6,
    "is_gender_restricted": 0,
    "is_sick_only": 1,
    "eligibility_strictness_score": 0.7,
    "emb_0": 0.0,
    "emb_1": 0.0,
    "emb_2": 0.0,
    "emb_3": 0.0,
    "emb_4": 0.0,
    "emb_5": 0.0,
    "emb_6": 0.0,
    "emb_7": 0.0,
    "emb_8": 0.0,
    "emb_9": 0.0,
    "emb_10": 0.0,
    "emb_11": 0.0,
    "emb_12": 0.0,
    "emb_13": 0.0,
    "emb_14": 0.0,
    "emb_15": 0.0,
    "emb_16": 0.0,
    "emb_17": 0.0,
    "emb_18": 0.0,
    "emb_19": 0.0,
    "min_p_value": 0.05
  }
}
